BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 19366842)

  • 41. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
    Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
    Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human recombinant activin-A alters pituitary luteinizing hormone and follicle-stimulating hormone secretion, follicular development, and steroidogenesis, during the menstrual cycle in rhesus monkeys.
    Stouffer RL; Woodruff TK; Dahl KD; Hess DL; Mather JP; Molskness TA
    J Clin Endocrinol Metab; 1993 Jul; 77(1):241-8. PubMed ID: 8325947
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ovarian response to recombinant human follicle-stimulating hormone in luteinizing hormone-depleted women: examination of the two cell, two gonadotropin theory.
    Ben-Chetrit A; Gotlieb L; Wong PY; Casper RF
    Fertil Steril; 1996 Apr; 65(4):711-7. PubMed ID: 8654626
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of luteinizing hormone on follicle stimulating hormone-activated paracrine signalling in rat ovary.
    Smyth CD; Miró F; Howles CM; Hillier SG
    Hum Reprod; 1995 Jan; 10(1):33-9. PubMed ID: 7745066
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Appropriate prolongation of GnRH-a down-regulation improves the synchronism of follicular development].
    Wang B; Sun HX; Liu JY; Hu YL; He FF
    Zhonghua Nan Ke Xue; 2011 Dec; 17(12):1087-91. PubMed ID: 22235676
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development.
    Schipper I; Hop WC; Fauser BC
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1292-8. PubMed ID: 9543158
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain.
    Burgués S;
    Hum Reprod; 2001 Dec; 16(12):2525-32. PubMed ID: 11726569
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Successful pregnancy and live birth from a hypogonadotropic hypogonadism woman with low serum estradiol concentrations despite numerous oocyte maturations: a case report.
    Matsumoto K; Imakawa K; Hayashi C
    BMC Pregnancy Childbirth; 2017 Sep; 17(1):312. PubMed ID: 28931393
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study.
    European Recombinant LH Study Group
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2607-18. PubMed ID: 11397861
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetic and pharmacodynamic interactions between recombinant human luteinizing hormone and recombinant human follicle-stimulating hormone.
    le Cotonnec JY; Loumaye E; Porchet HC; Beltrami V; Munafo A
    Fertil Steril; 1998 Feb; 69(2):201-9. PubMed ID: 9496329
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Ovarian response and induction of ovulation with human menopausal gonadotropin of different ratio of FSH to LH content in women with ovarian insufficiency].
    Koyama T; Kamata S; Kubota T; Ohara M; Ichimura M; Saito M
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):445-51. PubMed ID: 3131463
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of low dose purified FSH in ovulation induction following pituitary desensitization in polycystic ovarian syndrome.
    Buckler HM; Critchley HO; Cantrill JA; Shalet SM; Anderson DC; Robertson WR
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):209-17. PubMed ID: 8435902
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of theca cell function prior to controlled ovarian stimulation: the predictive value of serum basal/stimulated steroid levels.
    Hugues JN; Theron-Gerard L; Coussieu C; Pasquier M; Dewailly D; Cedrin-Durnerin I
    Hum Reprod; 2010 Jan; 25(1):228-34. PubMed ID: 19897528
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Follicular development induced by recombinant luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in anovulatory women with LH and FSH deficiency: evidence of a threshold effect.
    O'Dea L; O'Brien F; Currie K; Hemsey G
    Curr Med Res Opin; 2008 Oct; 24(10):2785-93. PubMed ID: 18727841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recombinant luteinizing hormone in ovarian hyperstimulation after stimulation failure in normogonadotropic women.
    Laml T; Obruca A; Fischl F; Huber JC
    Gynecol Endocrinol; 1999 Apr; 13(2):98-103. PubMed ID: 10399054
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
    Lasley BL; Wang CF; Yen SS
    J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women.
    Schoot DC; Harlin J; Shoham Z; Mannaerts BM; Lahlou N; Bouchard P; Bennink HJ; Fauser BC
    Hum Reprod; 1994 Jul; 9(7):1237-42. PubMed ID: 7962424
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of recombinant human LH and hCG on serum and urine LH and androgens in men.
    Handelsman DJ; Goebel C; Idan A; Jimenez M; Trout G; Kazlauskas R
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):417-28. PubMed ID: 19170708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.